Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CLEAR-2: Estradiol or Progesterone for Perimenstrual Suicidality
NCT03498313Phase 4Completed
- Sponsor
- University of Illinois Chicago
- Start
- Jul 2018
- Primary completion
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of estradiol topical, Crinone in suicidal ideation, sponsored by University of Illinois Chicago. Started Jul 2018; status: completed.
02
Drugs
estradiol topicalCrinone
03
Conditions
suicidal ideation
Beyond the preview
Go deeper on NCT03498313.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03498313.